Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial

Ania M. Jastreboff

Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT

Donna H. Ryan

Pennington Biomedical Research Center, Baton Rouge, LA

Harold E. Bays

Monroe Biomedical Research, Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY

Peter R. Ebeling

Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia

Mia G. Mackowski

Amgen, Thousand Oaks, CA

Nisha Philipose

Amgen, Thousand Oaks, CA

Leorah Ross

Amgen, Thousand Oaks, CA

Yimeng Liu

State Key Laboratory of NBC Protection for Civilian

Cassandra E Burns

Amgen, Thousand Oaks, CA

Siddique A. Abbasi

Amgen, Thousand Oaks, CA

Nicola Pannacciulli

Amgen, Thousand Oaks, CA